Director Karen Rapp offloaded 500 Plexus shares via a pre-planned 10b5-1 arrangement, maintaining a significant remaining stake of 7,535 shares as the stock continues to outperform the broader market.
Director Karen Rapp sold 500 shares under a pre-arranged 10b5-1 plan, with remaining holdings of 7,535 shares, indicating no negative signal.
Plexus Director Karen Rapp sold 500 shares of common stock on August 31, 2026, in a transaction valued at approximately $120,435. The sale was executed under a pre-arranged Rule 10b5-1 trading plan established in February, signaling a routine liquidity event rather than a shift in company outlook.
No. The sale was executed under a pre-arranged 10b5-1 plan established months prior, and the director maintains a substantial remaining equity position in the company.